EGFR and hepatocellular carcinoma: Most HCC cell lines exhibit high EGFR expression levels, and a clinical study conducted at Shanghai Renji Hospital (ClinicalTrials.gov, NCT04642547) suggested that lenvatinib in combination with gefitinib may be particularly beneficial for HCC patients with high EGFR expression level.43